We are live on ! Find out more
UFF

USA Financial Formulas Portfolio holdings

AUM $531M
1-Year Est. Return 28.6%
This Fund
S&P 500
This Quarter Est. Return
+6.38%
1 Year Est. Return
+28.6%
3 Year Est. Return
+77.97%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$65.1M
AUM Growth
+$3.38M
Cap. Flow
+$1.12M
Cap. Flow %
1.72%
Top 10 Hldgs %
32.36%
Holding
505
New
81
Increased
27
Reduced
140
Closed
15

Top Buys

Rank Stock Value
1
CPRT icon
Copart
CPRT
+$935K
2
ANSS
Ansys
ANSS
+$934K
3
CDNS icon
Cadence Design Systems
CDNS
+$866K
4
MDLZ icon
Mondelez International
MDLZ
+$836K
5
NFLX icon
Netflix
NFLX
+$836K

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$1.18M
2
GILD icon
Gilead Sciences
GILD
+$1.1M
3
ROST icon
Ross Stores
ROST
+$991K
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$984K
5
IWM icon
iShares Russell 2000 ETF
IWM
+$368K

Sector Composition

Rank Sector Weight
1 Healthcare 22.26%
2 Technology 14.97%
3 Industrials 14.19%
4 Consumer Discretionary 10.83%
5 Consumer Staples 8.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GPI icon
476
Group 1 Automotive
GPI
$3.18B
$258 ﹤0.01%
+1
New +$230
IP icon
477
International Paper
IP
$22B
$254 ﹤0.01%
8
– –
AA icon
478
Alcoa
AA
$13.2B
$238 ﹤0.01%
7
– –
WRK
479
DELISTED
WestRock Company
WRK
$233 ﹤0.01%
8
– –
CCI icon
480
Crown Castle
CCI
$32.2B
$228 ﹤0.01%
2
– –
NSC icon
481
Norfolk Southern
NSC
$75.1B
$227 ﹤0.01%
1
– –
CPT icon
482
Camden Property Trust
CPT
$11.1B
$218 ﹤0.01%
2
– –
MHK icon
483
Mohawk Industries
MHK
$9.22B
$206 ﹤0.01%
2
– –
FL
484
DELISTED
Foot Locker
FL
$190 ﹤0.01%
7
– –
DIS icon
485
Walt Disney
DIS
$181B
$179 ﹤0.01%
2
– –
SYNH
486
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$169 ﹤0.01%
4
– –
GEHC icon
487
GE HealthCare
GEHC
$32.4B
$81 ﹤0.01%
1
– –
FHI icon
488
Federated Hermes
FHI
$4.72B
$72 ﹤0.01%
+2
New +$77
TNDM icon
489
Tandem Diabetes Care
TNDM
$1.53B
$49 ﹤0.01%
2
– –
GSG icon
490
iShares S&P GSCI Commodity-Indexed Trust
GSG
$968M
$39 ﹤0.01%
2
– –
ACHC icon
491
Acadia Healthcare
ACHC
$2.94B
– –
-8
Closed -$578
ARMK icon
492
Aramark
ARMK
$14.7B
– –
-22
Closed -$573
BAH icon
493
Booz Allen Hamilton
BAH
$9.15B
– –
-6
Closed -$556
CASY icon
494
Casey's General Stores
CASY
$30.9B
– –
-2
Closed -$433
DINO icon
495
HF Sinclair
DINO
$14.5B
– –
-13
Closed -$629
DOX icon
496
Amdocs
DOX
$6.22B
– –
-7
Closed -$672
ENPH icon
497
Enphase Energy
ENPH
$5.53B
– –
-94
Closed -$19.8K
EOG icon
498
EOG Resources
EOG
$70.7B
– –
-199
Closed -$22.8K
ERIE icon
499
Erie Indemnity
ERIE
$13.2B
– –
-3
Closed -$695
NBIX icon
500
Neurocrine Biosciences
NBIX
$16.6B
– –
-5
Closed -$506
17 18 19
20
21

Similar funds

TM
Taproot Management New York $530M AUM
KI
Kapitalo Investimentos Sao Paulo, Brazil $531M AUM 25.72% 1-Year Est. Return
PWS
Proactive Wealth Strategies Marietta, Georgia $532M AUM 21.29% 1-Year Est. Return
SLC
Second Line Capital Metairie, Louisiana $528M AUM 16.68% 1-Year Est. Return
LSCM
Light Street Capital Management Palo Alto, California $534M AUM 59.08% 1-Year Est. Return
LIM
Lathrop Investment Management Little Rock, Arkansas $534M AUM 22.94% 1-Year Est. Return
DA
Drake & Associates Waukesha, Wisconsin $525M AUM 14.04% 1-Year Est. Return
SRFM
Shannon River Fund Management New York $524M AUM 90.54% 1-Year Est. Return

USA Financial Formulas's Q2 2023 Portfolio in Review

As of Q2 2023, USA Financial Formulas held 505 positions worth $65.1M, up 5.5% from $61.7M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

USA Financial Formulas's Q2 2023 filing shows 81 new, 27 increased, 140 reduced and 15 closed positions. Its largest new stake was Copart: 22,550 shares worth $1.03M. The largest sale was Biogen, an estimated $1.18M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 28% a quarter earlier, followed by Technology and Industrials.

  • USA Financial Formulas's largest Q2 2023 buy was Copart: 22,550 shares worth $1.03M.
  • USA Financial Formulas added most to Cadence Design Systems in Q2 2023, an estimated $866K increase.
  • USA Financial Formulas's biggest Q2 2023 reduction was Biogen, cutting an estimated $1.18M.
  • USA Financial Formulas fully exited Northrop Grumman in Q2 2023, selling an estimated $23.1K.
  • USA Financial Formulas's ten largest holdings make up 32% of its $65.1M portfolio in Q2 2023.
  • USA Financial Formulas opened 81 new positions and closed 15 in Q2 2023.
  • USA Financial Formulas's portfolio value rose 5.5% quarter-over-quarter to $65.1M.

Based on USA Financial Formulas's 13F filing for Q2 2023, filed 27 Nov 2023.